1. Home
  2. SSL vs TMDX Comparison

SSL vs TMDX Comparison

Compare SSL & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sasol Ltd.

SSL

Sasol Ltd.

HOLD

Current Price

$12.71

Market Cap

5.6B

Sector

Energy

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$99.61

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSL
TMDX
Founded
1950
1998
Country
South Africa
United States
Employees
27411
N/A
Industry
Oil & Gas Production
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.6B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SSL
TMDX
Price
$12.71
$99.61
Analyst Decision
Sell
Buy
Analyst Count
1
9
Target Price
N/A
$154.00
AVG Volume (30 Days)
2.9M
923.9K
Earning Date
04-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
382.18
EPS
N/A
4.87
Revenue
N/A
$605,494,000.00
Revenue This Year
N/A
$24.51
Revenue Next Year
$4.48
$18.73
P/E Ratio
$13.51
$20.97
Revenue Growth
N/A
37.13
52 Week Low
$2.78
$62.42
52 Week High
$13.02
$156.00

Technical Indicators

Market Signals
Indicator
SSL
TMDX
Relative Strength Index (RSI) 78.11 24.72
Support Level $6.09 N/A
Resistance Level N/A $131.86
Average True Range (ATR) 0.42 5.48
MACD 0.09 -2.58
Stochastic Oscillator 91.55 3.82

Price Performance

Historical Comparison
SSL
TMDX

About SSL Sasol Ltd.

Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: